| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |